TGS1 and cancer: Our data highlight a central role for TGS1-dependent 2,2,7-TMG capping of hTR to assure selective, telomerase-dependent telomere maintenance and restrict the formation of telomeric substrates that lead to aberrant ALT in telomerase-positive cancer cells.